MedTrace Logo

Treatment of Pediculosis (Head Lice) in Senegal

NCT03578679 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2019-02-27

No results posted yet for this study

Summary

This is a prospective single-arm interventional study evaluating Therapeutic efficacy of a combination of two pharmaceutical drugs, Azithromycin (AZIT) and Ivermectin (IVER) administered orally in the treatment of head lice infestations. In case of persistence of lice and / or nits on day 7, a second oral administration of combination Azithromycin + Ivermectin will be considered.

The duration of the study period is 4 months, ie 1 month and ½ of inclusion and 2 months and ½ feedback. There will be a site initiation visit "site initiation visit" before inclusions at D-7, two monitoring visits and a closing visit "close out visit" at the end of the follow-up at 4 months.

Conditions

  • Pediculoses

Interventions

DRUG

Ivermectin Oral Product

treatment of pediculosis (head lice)

Sponsors & Collaborators

  • Institut de Recherche pour le Developpement

    lead OTHER_GOV

Principal Investigators

  • Cheikh Sokhna, PhD · Institut de Recherche pour le Developpement

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-11
Primary Completion
2019-01-31
Completion
2019-02-24

Countries

  • Senegal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03578679 on ClinicalTrials.gov